000547:SZSEAddsino Co., Ltd. Analysis
Data as of 2026-03-16 - not real-time
CN¥31.87
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Addsino Co., Ltd. is trading around 31.87 CNY, well above its DCF‑derived fair value of ~4 CNY, implying a severe pricing disconnect. The forward P/E of 77.7× dwarfs the industry average of 34.3×, while the price‑to‑book sits at 10.8×, further underscoring an overvalued stance. Technical signals are mixed: the MACD line remains just above its signal, producing a modest bullish histogram, and the RSI sits near the neutral 54 level, suggesting limited upside momentum. Fundamental health is weak, with negative gross (‑13.8%) and operating margins, a trailing EPS of ‑1.01, and a high debt‑to‑equity ratio exceeding 17, raising concerns about profitability and balance‑sheet resilience.
Liquidity appears adequate given stable, high trading volumes, but the company faces heightened sector and regulatory risks tied to China’s defense‑related technology space, alongside geographic concentration risk. The extreme “Greed” reading on the fear‑greed index reflects market optimism that may be unjustified given the stark valuation gap and deteriorating earnings profile. Investors should weigh the modest technical bullishness against the fundamental overvaluation and risk backdrop before making a call.
Liquidity appears adequate given stable, high trading volumes, but the company faces heightened sector and regulatory risks tied to China’s defense‑related technology space, alongside geographic concentration risk. The extreme “Greed” reading on the fear‑greed index reflects market optimism that may be unjustified given the stark valuation gap and deteriorating earnings profile. Investors should weigh the modest technical bullishness against the fundamental overvaluation and risk backdrop before making a call.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Technical MACD bullish crossover but weak momentum
- Severe overvaluation relative to DCF and peers
- Stable liquidity mitigating immediate price pressure
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings deficits and negative margins
- Persistently high forward P/E versus industry
- Regulatory scrutiny in China’s defense‑tech sector
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental deterioration with negative EPS and high debt
- Valuation gap unlikely to close without structural turnaround
- Elevated sector and regulatory risks in a geopolitically sensitive market
Key Metrics & Analysis
Financial Health
Revenue Growth209.20%
Profit Margin-67.50%
P/E Ratio77.7
ROE-27.20%
ROA-7.74%
Debt/Equity17.37
P/B Ratio10.8
Op. Cash FlowCN¥333.4M
Free Cash FlowCN¥164.4M
Industry P/E34.3
Technical Analysis
TrendNeutral
RSI54.3
SupportCN¥26.86
ResistanceCN¥34.30
MA 20CN¥30.54
MA 50CN¥30.75
MA 200CN¥15.09
MACDBullish
VolumeStable
Fear & Greed Index78.29
Valuation
Fair ValueCN¥4.03
GradeOvervalued
TypeValue
Risk Assessment
Beta0.19
Volatility77.68%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.